ENDRA LIFE SCIENCES INC. Adjustments to Additional Paid in Capital, Fair Value
ENDRA LIFE SCIENCES INC. (NDRA) reported Adjustments to Additional Paid in Capital, Fair Value of $39.96 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2026-03-31
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, fair value for the quarter ending 2025-09-30 was $39.96K.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, fair value for the quarter ending 2024-12-31 was $104.69K.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, fair value for the quarter ending 2024-09-30 was -$36.85K.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, fair value for fiscal 2024 was $491.92K.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 3 month | Adjustments to Additional Paid in Capital, Fair Value 6 month | Adjustments to Additional Paid in Capital, Fair Value 9 month | Adjustments to Additional Paid in Capital, Fair Value 12 month |
|---|---|---|---|---|
| 2025-09-30 | $39.96K 10-Q · filed 2025-11-14 | $172.24K 10-Q · filed 2025-11-14 | ||
| 2024-12-31 | $104.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $67.84K derived: sum of 2 quarters · filed 2026-03-31 | $491.92K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$36.85K 10-Q · filed 2025-11-14 | $387.24K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |